Lataa...
Advanced Care Provider and Nursing Approach to Assessment and Management of Immunotherapy-Related Dermatologic Adverse Events
Advanced care providers (ACPs) and nurses are fundamental players in the assessment and management of immunotherapy-related dermatologic adverse events (irdAE). Pembrolizumab, nivolumab, and ipilimumab are approved for unresectable or metastatic melanoma, metastatic non–small cell lung cancer (pembr...
Tallennettuna:
| Julkaisussa: | J Adv Pract Oncol |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Harborside Press
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5995492/ https://ncbi.nlm.nih.gov/pubmed/29900022 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|